InvestorsHub Logo
Post# of 7609
Next 10
Followers 85
Posts 17667
Boards Moderated 4
Alias Born 05/13/2001

Re: None

Friday, 07/06/2007 9:59:57 AM

Friday, July 06, 2007 9:59:57 AM

Post# of 7609
HDVY - Health Discovery Corporation Settles Patent Infringement Suit against Ciphergen Biosystems, Inc.
Ciphergen to License HDC's Support Vector Machine Technology
Jul 6, 2007 9:27:00 AM
Copyright Business Wire 2007
SAVANNAH, Ga.--(BUSINESS WIRE)--

Health Discovery Corporation ("HDC") (OTCBB:HDVY) today announced that its patent infringement action against Ciphergen Biosystems, Inc. has been settled. Under the terms of the agreement, Ciphergen will pay $600,000 to HDC and receive a non-exclusive license to use HDC's support vector machines in applications for Ciphergen's proprietary SELDI-based technologies. Ciphergen also dropped all counter-claims against HDC.

"This settlement is an excellent resolution for our company and shareholders," said Stephen D. Barnhill, M.D., HDC's Chairman and CEO. "It is also the second favorable outcome in both of the patent infringement suits we've filed, adding credence and momentum to our ongoing licensing efforts. HDC remains firmly committed to monetizing our valuable intellectual property through close collaboration and development with our business partners, but we will also continue to protect our patent portfolio through robust enforcement action when necessary."

Savannah-based Health Discovery Corporation (OTCBB:HDVY) is uniquely positioned in the field of pattern recognition technology. Through the application of its patent protected technology, HDC is a biology-oriented biomarker discovery company providing all aspects of First-Phase Biomarker Discovery sm. The Company's SVM and RFE-SVM pattern recognition tools have significant application potential in other sizable commercial markets such as radiology, financial markets, Internet search and spam, homeland security, and other areas where analysis of large volumes of complex data is required.

This news release contains "forward-looking statements" within the meaning of Section 27a of the Securities Acts of 1933 and Section 21E of the Securities Exchange Act of 1934. Although the management team of HDC believes that the expectations reflected in such forward-looking statements are reasonable, they can give no assurance that such expectations will prove correct.

Source: Health Discovery Corporation



----------------------------------------------
Health Discovery Corporation
Daniel R. Furth
813-716-4783
investor@healthdiscoverycorp.com
www.healthdiscoverycorp.com


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.